ARTICLE | Company News
Ambrilia cancer, infectious news
February 16, 2009 8:00 AM UTC
Ambrilia retained Boenning & Scattergood Inc. to review strategic alternatives. The company also said it has completed its previously announced headcount reductions, including its CSO and Senior EVP B...